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Abstract
Background: Royal jelly is a nutritious substance produced by the young nurse bees and contains significant amounts of proteins which are
important for cell growth and proliferation. The aim of this study was to evaluate the effect of royal jelly as an alternative to fetal bovine serum
(FBS) in cell culture using cell proliferation assays and live cell imaging.
Materials and Methods: MRC-5 cells were treated with various concentrations of royal jelly extract in MTT assay. The control groups were
comprised of Alpha-Minimal Essential Medium (α-MEM) alone and α-MEM with 10% FBS. Subsequently, the cell proliferation was studied for 
10 days using Alamar Blue assay and live cell imaging from 48 to 72 h. The population doubling time (PDT) was determined using trypan blue
assay after live cell imaging.
Results: In MTT assay, 0.156 and 0.078 mg/ml of royal jelly produced higher cell viability compared to positive control group but were not
significantly different (P > 0.05). In the Alamar Blue assay, 0.156 and 0.078 mg/ml of royal jelly produced greater percentage of reduction at day
3 even though no significant difference was found (P > 0.05). Based on live cell imaging, the PDT for positive, negative, 0.156 and 0.078 mg/ml
of royal jelly groups were 29.09, 62.50, 41.67 and 41.67 h respectively. No significant difference was found in the PDT between all the groups (P
> 0.05).
Conclusion: Royal jelly does not exhibit similar ability like FBS to facilitate cell growth under the present test conditions.
Keywords: Royal jelly, proliferation, cell division, live cell imaging
Introduction
Among foods that possess the characteristic of functionality include all those that originated in beehive. Royal jelly is one of the
consumable bee products besides honey and propolis (Viuda-Martos et al., 2008). Royal jelly is a substance of complex chemical structure
produced by the young nurse bees and secreted from glands on the tops of their heads (Yatsunami et al., 1987). Royal jelly is produced
exclusively for the nourishment of the queen bee for the whole life and for 2-3 days. Royal jelly is the only food given to all young larvae
(Brouwers et al., 1987). Due to this condition, the queen bees develop superior characteristics of size, strength and longevity. The dramatic effects
on the queen bee’s growth and lifespan has led to many clinical studies to find out whether any of its properties can benefit human beings. Royal
jelly contains remarkable amounts of proteins, lipids, glucides, vitamins, hormones, enzymes, and mineral substances (Howe et al., 1985). The
composition of elements in the royal jelly are water (50% to 60%), proteins (18%), carbohydrates (15%), lipids (3% to 6%), mineral salts (1.5%),
and vitamins (trace amount) (Nagai and Inoue, 2004). A large number of bioactive substances such as 10-hydroxyl-2-decenoic acid (10H2DA)
(Caparica-Santos and Marcucci, 2007) with immunomodulating properties (Ferlat et al., 1994), antibacterial protein, royalisin (Fujiwara et al.,
1990; Eshraghi and Seifollahi, 2003), fatty acids (Vucevic et al., 2007), and peptides (Tokunaga et al., 2004) make up some of the components in
royal jelly. It is reported that DIII protein contained in royal jelly can stimulate cell proliferation and seemed useful as a supplement to the serum
free medium (Watanabe et al., 1998). Many scientific studies claimed that royal jelly has pharmacological properties such as antioxidant,
neurotrophic, hypoglycemic, hypocholesterolemic, hepatoprotective, hypotensive and blood pressure regulatory, anti-tumour, antibiotic, anti-
inflammatory, immunomodulatory and anti-allergic, general tonic and anti-aging agent due to its complex composition (Mărghitaş, 2008). 
Though the use of royal jelly in many medical fields has been established as mentioned earlier, its role in cell culture has not been reported yet.
Based on the nutritional properties of royal jelly, it has the potential to replace the fetal bovine serum (FBS) that is widely used in cell
culture media as a supplement. Cell or tissue culture routinely requires the application of animal-derived products or serum as components in
culture medium. One particular example is FBS. FBS contains a mixture of biomolecules which promote cell growth and stimulate proliferation
of cell. Because of its rich content of growth factors and its low gamma-globulin content, FBS has become the standard supplement of cell culture
media. FBS is good for cell attachment, growth and proliferation in vitro (Gstraunthaler, 2003). FBS is obtained from bovine fetus via closed
system of collection at the slaughterhouse. The usage of fetal bovine serum may involve both moral and scientific problems with the composition
varying between batches and having a possibility of contamination with viruses, mycoplasma and prions (Eliot, 1999; Shah, 1999; Wessman and
Levings, 1999; Gstraunthaler, 2003). Due to those issues regarding the application of FBS, an alternative to the animal serum is needed
particularly for cell culture purpose. Royal jelly that has been known as a nutritious supplement and contains elements like proteins which are
important for cell growth may potentially act as the substitute for FBS. Another bee product that has been studied to be used as supplement to
FBS was Tualang honey (Kannan et al., 2009). It is essential for an alternative material to replace FBS to have similar constituents or components
which enable cells to grow. Hence, the present study aims to evaluate royal jelly as an alternative to fetal bovine serum in cell culture using MTT
assay, Alamar Blue assay and live cell imaging on human lung fibroblast cell line (MRC-5).
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Materials and methods
Royal jelly
The royal jelly used in the present study was from Acacia sp. tree, originally from Malaysia.
Cell line
Human fibroblast cell line (CCL-171) designated as MRC-5 was obtained from American Type Culture Collection (ATCC), USA.
Reagents
Reagents included the following: Alpha-Minimal Essential Medium (α-MEM) (IX) (GIBCO, USA), Penicillin (5000 units/ml) and 
Streptomycin (5000 μg/ml) antibiotic solutions (GIBCO, New Zealand), FBS (GIBCO, New Zealand), trypsin-EDTA (0.25%) solution (GIBCO, 
New Zealand), phosphate buffered saline IX (PBS) (GIBCO, New Zealand), trypan blue dye (0.4%) (Invitrogen, USA), CellLightTM Nucleus-
GFP and CellLightTM Mitochondria-RFP (BacMam 2.0) fluorescent expression systems (Life technologies, USA).
Royal jelly extraction
Royal jelly (0.5 g) was weighed and put into 1.5 ml sterile centrifuge tube. The sample was then sterilised by exposing it to 25 kGy of
gamma (γ) radiation. Extract of royal jelly was prepared by diluting the royal jelly in culture medium (α-MEM) without addition of FBS, 
supplemented with 1 % of penicillin-streptomycin antibiotic mixture. The concentration of stock prepared was 5 mg/ml, which was stored at 4ºC
until use. For the testing, royal jelly stock was diluted into desired concentrations using culture medium, α-MEM which was prepared as 
mentioned earlier.
Cell culture
MRC-5 cells were grown in α-MEM with L-Glutamine and without ribonucleoside and deoxyribonucleosides, supplemented with 10% 
FBS and 1% of penicillin-streptomycin antibiotic mixture. The cells were maintained at 37ºC in a humidified incubator supplemented with 5%
CO2.
Cytotoxicity test
Cytotoxicity of royal jelly on MRC-5 cell line was studied using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay which was developed by Mosmann (1983). Confluent MRC-5 cells were washed with PBS and trypsinized using trypsin-EDTA solution.
Cells were then centrifuged at 1200 rpm for 5 min and the cell pellet was re-suspended in the medium. Ten microlitre of cell suspension was
mixed with 10 µl of 0.4% trypan blue solution and the number of viable cells were counted using haemocytometer. MRC-5 cells (1 x 104) were
seeded onto triplicate 96-well plate and treated with different concentrations of royal jelly extract (2.5, 1.25, 0.625, 0.313, 0.156 and 0.078
mg/ml) for 72 hours. Two controls were included in the test. For negative control wells, only α-MEM and cell suspension were added, while cell 
suspension together with α-MEM and 10% FBS were added into the positive control group wells.  Penicillin-streptomycin at the rate of 1% was 
added into both culture media. Ten microlitre of 0.5 mg/ml MTT solution which was diluted with PBS was added into all wells following the
incubation period. The cells were incubated further for 4 hours at 37ºC and then the medium was removed. Formazan crystals formed in wells
were dissolved by adding 100 µl of DMSO into each well. Absorbance of each group was read at 570 nm using ELISA plate reader (Tecan,
Switzerland). The relative viability of the cells compared to the control was determined using the following formula:
% Cell Viability = [A570 of treated cells] x 100% / [A570 of control cells]
Concentration of royal jelly which produced cell viability greater than positive control (α-MEM + 10% FBS) was used for the cell proliferation 
assay. From MTT assay result, dose inhibition graph was constructed. The morphology of cells incubated with royal jelly extract also was
observed at the end of the incubation period (72 hours).
Cell proliferation assay (Alamar Blue assay)
Standard curve for MRC-5 cells was constructed prior to treatment with royal jelly where different numbers of MRC-5 cells (50000,
25000, 12500, 6250, 3125, 1563, 781, 391 cells) were incubated for 24 hours before Alamar Blue dye was added. For Alamar Blue assay, 2 x 103
of cells were seeded in 96-well plate and treated with concentrations of royal jelly from MTT assay result, concurrently with positive (α-MEM + 
10% FBS) and negative control (α-MEM only) for 24 hours. All culture medium was supplemented with 1% penicillin-streptomycin. After 
incubation period, 10 µl of Alamar Blue dye was added and the plate was further incubated for 4 hours. Then, the medium was aspirated into
another 96-well plate and the absorbance of each well was read at 570 and 600 nm using ELISA plate reader. Alamar Blue assay was conducted
over a period of 10 days and carried out in triplicates. Percentage of reduction (% reduction) of Alamar Blue for all groups was calculated using
the formula derived by Willard et al. (1965) as given below:
% reduction = [(117.216) A570- (80.586) A600] / [(155.677) A’600-(14.652) A’570] x 100%
Where 117.216: molar extinction coefficient of Alamar Blue in the oxidized form at 600 nm; 80.586: molar extinction coefficient of Alamar Blue
in the oxidized form at 570 nm; 14.652: molar extinction coefficient of Alamar Blue in the reduced form at 600 nm; 155.677: molar extinction
coefficient of Alamar Blue in the reduced form at 570 nm; A600: absorbance of test wells at 600 nm; A570: absorbance of test wells at 570 nm;
A'600: absorbance of negative control wells at 600 nm; A'570: absorbance of negative control wells at 570 nm.
Graph of percentage of reduction of all groups over time was constructed. Greater percentage of reduction represented higher level cell
growth.
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Live cell imaging (Determination of population doubling time)
MRC-5 cells were seeded in four-compartments, 35mm tissue culture dish at a cell density of 3 x 103 cells. The cells were incubated
either with concentrations of royal jelly from MTT assay result, positive control (α-MEM with 10% of FBS) or negative control (α-MEM only). 
The experiments were conducted in triplicates. After overnight incubation, 0.6 µL of CellLightTM Nucleus-GFP (BacMam 2.0) and CellLightTM
Mitochondria-RFP (BacMam 2.0) fluorescent expression system was then added into each compartment of tissue culture dish. The cells were then
incubated at 37°C in a humidified incubator supplemented with 5% CO2 for at least 16 hours. Prior to the live cell imaging test, the medium was
changed and PBS was used to wash the cells. New culture medium and royal jelly extract without addition of fluorescent expression system were
added into the wells. The cells were subjected to live cell imaging at 48 to 72 hours after cell seeding. Images of cells were captured every half
hour for 24 hours by using live cell imaging system (Vivatome, Zeiss, Germany) and analysed using Axio Vision Rel. 4.8 software (Zeiss,
Germany) where a video was produced over the period of incubation. Cell division process was observed and any changes in cell morphology
were noted.
As the live cell imaging is a qualitative analysis, trypan blue assay was performed to quantify the number of viable cells in all groups.
Following the incubation for live cell imaging (72 hours after cell seeding), the cells were washed, trypsinized and counted as mentioned earlier
in the MTT assay section. The cell number was noted for the determination of population doubling time (PDT). PDT refers to the time it would
take a population to double, assuming there is a constant growth rate (Teisch and De Sherbinin, 1995). PDT was measured using the following
formula (Mather and Roberts, 1998):
PDT = 1/r
Where, multiplication rate (r): 3.32 (log NH – log N₁) / (t₂ - t₁); N1: cell number at 0 hour (3 x 103 cells); NH: cell number at 72 hours
Statistical analysis
Results of MTT assay, Alamar Blue test and live cell imaging between treatment groups were analysed using independent t-test using
PASW statistical software package, version 18.0.1 (SPSS Inc., USA) for Windows. Differences were considered statistically significant when the
P-value was < 0.05.
Results
Cytotoxicity test (MTT assay)
For cytotoxicity evaluation of royal jelly on MRC-5 cells, different concentrations of royal jelly extract (2.5, 1.25, 0.625, 0.313, 0.156
and 0.078 mg/ml) produced 71.46%, 77.29%, 86.30%, 83.02%, 89.94% and 90.67% of cell viability respectively. Cells treated with α-MEM + 
10% FBS produced 87.52% of viability. The relative viability of the cells compared to the control is shown in Figure 1.
Figure 1: MTT assay of royal jelly on human lung fibroblast cell line (MRC-5)
Concentrations of royal jelly which produced cell viability higher than positive control (α-MEM + 10% FBS) were used for cell 
proliferation assay. Two concentrations of the royal jelly extract (0.156 and 0.078 mg/ml) were selected for further tests. No significant difference
in viability of cells was found between α-MEM + 10% FBS and both royal jelly (0.156 and 0.078 mg/ml) groups (P > 0.05). The morphology of
cells treated with 0.156 and 0.078 mg/ml of royal jelly for 72 hours also were compared with that of the positive control. Royal jelly did not
exhibit cytotoxic effect on MRC-5 cells where both concentrations (0.156 and 0.078 mg/ml royal jelly) showed almost similar cellular
morphology with α-MEM + 10% FBS group (Figure 2). 
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Cell proliferation assay (Alamar Blue assay)
From Alamar Blue assay, standard curve for MRC-5 cells was constructed to investigate the growth pattern of the cell lines. In Figure 3,
the cell number of MRC-5 cell line was proportional to percentage of reduction where higher cell count produced greater Alamar Blue dye
reduction.
Figure 2: Cellular morphology of MRC-5 cells treated with (a) 0.156 mg/ml royal jelly; (b) 0.078 mg/ml royal jelly, and (c) Positive control (α-
MEM + 10% FBS)
Figure 3: Standard curve of MRC-5 cells for Alamar Blue assay
Effect of royal jelly on cell proliferation studied using Alamar Blue assay was shown in Fig 4. On Day 1, there was difference in the
value of percentage of reduction between all groups. Statistically, 0.078 mg/ml royal jelly produced no significant difference in percentage of
Alamar Blue reduction compared to positive control (P > 0.05). However, there was significant percentage of reduction between positive and
negative controls (P < 0.05). Throughout the experiment, 0.156 and 0.078 mg/ml royal jelly groups produced decreasing percentage of reduction,
unlike the positive control where the value increased over time.
From Day 1 to Day 7, both groups treated with royal jelly extract produced higher percentage of reduction than negative control. On the
third day of experiment, both 0.156 and 0.078 mg/ml royal jelly produced higher percentage of reduction compared to positive and negative
controls even though no significant difference was found between all groups (P > 0.05). At Day 7, percentage of reduction in royal jelly treatment
groups differed significantly with positive groups (P < 0.05). On the final day of the experiment (Day 10), it was found that the percentage of
reduction of 0.156 and 0.078 mg/ml royal jelly groups was significantly different from that of the positive control (P < 0.05), though not
significantly different from the negative control (P > 0.05).
Figure 4: Results of Alamar Blue test on MRC-5 cells treated with 0.156 and 0.078 mg/ml of royal jelly (RJ), positive and negative control
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Live cell imaging
For live cell imaging, a video was produced from the images captured every 30 minutes for the duration of 24 hours of the experiment.
Fig 5 shows the representative images of each treatment groups at the early (48 hours) and end (72 hours) of the study. As a surface adherent type
of cell, MRC-5 cells in healthy state appear to have elongated, fibrous shape. As the cell begins to divide, it undergoes morphological changes.
Cell division process started when there was change in the fibrous shape of the MRC-5 cells. At the initial stage of cell division, the cells became
round over time. The nucleus then was split into two which indicated the nuclear division process. Lastly, the cytoplasm divided and in the end
produced two daughter cells from a mother cell through cytokinesis. The cells then separated from each other. After few hours, the cells became
elongated, representing the further stage in cell attachment (Figure 6). The duration for a cell division process to be completed was 7±3 hours
based on the observation in live cell imaging.
Figure 5: Representative images of MRC-5 cells treated with royal jelly through live cell imaging. a negative control (0 h); b negative control (24
h); c positive control (0 h); d positive control (24 h); e 0.156 mg/ml of royal jelly (0 h); f 0.156 mg/ml of royal jelly (24 h); g 0.078 mg/ml of
royal jelly (0 h) and h 0.078 mg/ml of royal jelly (24 h) (Scale bar: 50 µm)
Figure 6: Cell division process of MRC-5 cells (negative control). a After 7.30 h (single cell); b After 10.30 h; c After 12.30 h; d After 13.00 h; e
After 13.30 h; f After 14.00 h; g After 14.30 h and h After 15.00 h (two daughter cells). Arrow denotes the individual cells.
For the determination of the PDT, numbers of cells at the end of the experiment were counted. Table 1 shows the PDT of all treatment
groups. Positive control (α-MEM + 10% FBS) produced the lowest PDT compared to royal jelly groups and negative control. PDT for negative 
control (α-MEM without addition of FBS) was the highest, suggesting slower cell proliferation compared to other groups. Even though there are 
differences in the mean PDT values, no statistical difference in PDT was found between groups (P > 0.05).
Table 1: Mean PDT of treatment groups
Treatment group PDT (Hours)c
Positive controla 29.09
Negative controlb 62.50
0.156 mg/ml RJ 41.67
0.078 mg/ml RJ 41.67
a α-MEM + 10% FBS, b α-MEM, c Mean PDT of the three independent tests
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Discussion
MTT assay
MTT assay is a sensitive, quantitative and reliable colorimetric assay which measures viability, proliferation and activation of cells. The
assay is based on the ability of the cellular mitochondrial dehydrogenase enzyme in living or viable cells to reduce the yellow water-soluble
substrate 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide into a dark blue/purple formazan product which is insoluble in water. The
quantity of formazan produced is directly proportional to the number of cells (Mosmann, 1983; Gerlier and Thomasset, 1986).
In MTT assay, analysis of different concentrations of royal jelly on cell viability revealed that the viability of cells was not proportional
to the concentrations of royal jelly. Dose dependent relationship was observed where the viability of cells decreased with increase in
concentrations of royal jelly. Cells treated in less diluted royal jelly extract produced lower percentage of viability (Figure 1) as more acidic pH of
higher concentration of royal jelly will inhibit the growth and viability of cells. pH of fresh royal jelly is found to be low and in acidic range (pH
of 3.4-4.5) (Sabatini et al., 2009). Lower concentration of royal jelly might serve a more suitable pH for the cells to grow and proliferate
compared to higher concentrations of the extract. As two concentrations of royal jelly extract (0.156 and 0.078 mg/ml) produced greater cell
viability compared to α-MEM supplemented with 10% FBS, it shows the potential of royal jelly at these concentrations to exhibit similar ability 
like FBS. Hence, this data supports the results of earlier studies where royal jelly proteins were reported to stimulate the proliferation of U-937
monocytic human cells (Watanabe et al., 1998) and hepatocyte DNA synthesis and albumin production (Kamakura et al., 2001). This occurs
through activation of several important intracellular signalling factors which is involved in stimulation of synthesis of hepatocyte DNA. 57-kDa
protein in royal jelly is also involved in the protection of cells from apoptosis (Kamakura, 2002). Salazar-Olivo and Paz-González in 2005 also
suggested that royal jelly contains growth factors or hormones promoting cell growth.
Alamar Blue assay
Alamar Blue (AB) is a tetrazolium-based dye which incorporates resazurin and resorufin as oxidation–reduction indicators that yield
colorimetric changes and a fluorescent signal in response to metabolic activity. The blue non-fluorescent colour in oxidised form becomes pink
and fluorescent upon reduction (DeBaun and de Stevens, 1951; Page et al., 1993). As the concentration of viable cells increased, greater
percentage of reduction is produced (Byth et al., 2001) which is translated as a sigmoid curve of standard (reference) graph. This has also been
observed in the current study (Fig 3). Higher percentage of Alamar Blue reduction in MRC-5 cells was seen in the viable cell count <20000. This
was supported by previous research which stated the reduction of Alamar Blue as detected by fluorescence that increased proportionally with
fibroblast cell number over the range of 100 to 20000 cells (Voytik-Harbin et al., 1998). In the present study, the detection of dye reduction was
performed using absorbance. Another method to quantify the Alamar Blue reduction is using fluorescence. Both absorbance and fluorescence
methods offered excellent sensitivity and reproducibility (Voytik-Harbin et al., 1998).
The proliferation activity of the cells indicates the occurrence of cell division process. Proliferating cells have to replicate the entirety of
their cellular contents in order to divide (Lemons et al., 2010). Based on the results of Alamar Blue assay (Fig 4), both royal jelly groups
produced decreased percentage of reduction over time starting from day 3 onwards and a plateau could be observed at the middle stage of the
experiment (days 4, 5 and 6). A plateau in dye reduction was produced with high cell densities and/or extended incubation times for the
percentage of reduction, followed by a decline in absorbance or fluorescence. This has been noted by the manufacturer and has also been
described for mammalian cells (Larson et al., 1997; Voytik-Harbin et al., 1998). This might explain the pattern in dye reduction seen in royal jelly
groups. In positive controls, the percentage of Alamar Blue reduction increased over time, showing the proliferative activity of MRC-5 cells in α-
MEM + 10% FBS. From the Alamar Blue test results, even though there are differences in royal jelly and positive control group, it was hard to
draw a conclusion on the proliferative rate of the treated cells as plateau and reduction in absorbance reading of royal jelly might be a result of
active proliferative effect.
Live cell imaging
Live cell imaging as a new method in imaging has served as a valuable method to analyse the cellular activity. The recent
improvements in imaging technology were contributed by the advancements in photochemistry/photobiology where development of sophisticated
molecular probes which allowed the visualisation of discrete molecules within living cells (Lippincott-Schwartz et al., 2001; Rieder and
Khodjakov, 2003). A major development in the field of bioimaging was the discovery of green fluorescent protein (GFP) (reviewed in Lippincott-
Schwartz and Patterson, 2003) which allows the visualisation and imaging of individual protein. Chimeras made from any gene of interest
coupled with GFP and with genetically engineered chromatic variations of GFP can be easily introduced into the cultured cells and genetically
tractable organisms (Haraguchi, 2002; Zhang et al., 2002). The nature in which these GFP fusions retain their native biological activity while
being fluorescently tagged made it a powerful tool for the investigation of dynamics of individual proteins at single cell level (Hinchcliffe, 2005).
The application expression of fluorescent proteins such as GFP in live cell imaging enables the detailed study of cell division in living
cells (Rusan et al., 2001; Wang, 2001; Wadsworth and Khodjakov, 2004). The analysis of division of cell in fixed cells presented limitations to
the researchers as many key events during mitosis occur only transiently. Dramatic changes in morphology of the spindle over the period of an
hour or less and the significance of these events are often lost in fixed time-point samples. Continuous imaging, as in live cell imaging, acted as a
solution to these problems. Video microscopy also provides the ability to determine the duration of an event and to examine the dynamic
redistribution of the structural and regulatory proteins (Hinchcliffe, 2005).
In the present study, the expression of GFP and red fluorescence protein (RFP) of cells using live cell imaging was analysed using
CellLight® (BacMan 2.0) fluorescence expression system. Fluorescence proteins (FPs) targeted to cell organelles by specific protein localisation
signals enable visualisation of their morphology, fusion and ﬁssion, and also segregation during cell division. FPs act as an essential tool for 
individual cell labelling and tissue labelling to visualise morphology, location, and movement, mitotic stages, and many other important cell
characteristics (Chudakov et al., 2010). CellLight® reagents are fluorescent protein-signal peptide fusions for live-cell imaging purpose. Cellular
labelling utilises BacMam technology, which uses an insect cell virus (baculovirus) coupled with a mammalian promoter and involves
transfection of human cells (Fornwald et al., 2007) to generate a stable line constitutively expressing nucleus-GFP and mitochondria-RFP without
affecting the cell cycle progression, as in the present study. As seen in the current study, the expression of nucleus-GFP and mitochondria-RFP in
MRC-5 resulted in green fluorescent colour of the nucleus and red fluorescent colour of the mitochondria. In this study, we investigated the
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proliferation effect of MRC-5 cells treated with either royal jelly extract (0.156 and 0.078 mg/ml), positive and negative control via live cell
imaging method with the aim of observing the cell division of MRC-5 cells treated with royal jelly. Two different concentrations of royal jelly
were selected based on the previous test (MTT assay) in which 0.156 and 0.078 mg/ml royal jelly produced proliferation rate comparable with
positive control (α-MEM + 10% FBS). Live cell imaging was performed from 48 to 72 hours after seeding based on the Alamar Blue assay 
results, where both royal jelly groups produced higher percentage of reduction compared to positive and negative controls from Day 2 to 3.
Proliferative capacity which contributes to cells’ lifespan in vitro has been reported to vary significantly with lots of serum (Schneider
et al., 1978). The reduction in the concentration of serum resulted in the reduced MRC-5 cells’ growth and attachment (Wistrom and
Villeponteau, 1990). A study by Burgener et al. (2002) reported the duration for cell division of MRC-5 cells of 34.0 hours in serum-
supplemented (5% FBS) Dulbecco Modified Essential Medium (DMEM) medium for cell count of up to maximum density of cells of 1 x 106
cells/ ml. The difference in the concentration of serum proved to be an essential factor in determining the time needed for cell division as for the
MRC-5 cells cultured in DMEM medium with 10% of FBS resulted in much lower doubling time (approximately 24 hours) which indicated more
active proliferation activity (Strait et al., 2005). However, in the present study, the PDT of cells treated in complete medium (α-MEM + 10% 
FBS) is 29.09 hours, higher than time duration as reported earlier. This may be due to the use of different culture medium in the current study
which was α-MEM and not DMEM. The calculated PDT values also differed from the duration for completion of a cell division process (7±3 
hours) observed in live cell imaging video as the division of cells seen in live cell imaging only indicated the mitosis stage of the cell cycle, not
involving the other stages in cell cycle. Cell cycle can be divided into 4 stages; G1, S, G2 and M. Morphologically, the cell cycle is classified into
interphase (G1, S, G2) and stages of M (mitosis), which include prophase, metaphase, anaphase and telophase (Alberts et al., 1983). However, as
the determination of each stage of cell cycle was not performed during live cell imaging, it was impossible for the analysis of the exact time for
the starting of the different phases of cell cycle in the cell division. Both royal jelly groups produced same PDT which suggests similarity in the
proliferation rate of cells treated with 0.156 and 0.078 mg/ml of royal jelly. Based on the live cell imaging, there were differences in the
appearance between the culture medium and royal jelly extract groups as insoluble royal jelly which floated in the extract of royal jelly was
noticed (Fig 5). This insolubility property of royal jelly was supported by Bogdanov (2011) where royal jelly was found to be only partially
soluble in water at a density of 1.1 g/ ml. Though insoluble royal jelly can be removed from the medium by using the filter, this was not applied in
this study as the process of filtration might eliminate the components present in the royal jelly, thus changing its properties. Some limitations
were observed in this study. As only a field was subjected to live cell imaging, there was a possibility of error occurring during the test. From the
live video of each treatment groups including positive and negative control, it was noticed that the cells moved as the cell division took place.
Due to this action, some cells were out of the focussed field throughout the 24 hours of incubation, resulting in an inadequate analysis of the cell’s
division and its changes in the morphology. The PDT determination also was done by trypan blue assay after the live cell imaging as there was
inaccurate reading based on the counting of cells at the start (48 hours) and end (72 hours) directly from the live cell imaging image due to the
problem mentioned earlier. As only a fixed field was used in the live cell imaging and there were movement of cells into/out of the field, it was
not possible to determine the exact number of cells in the treatment groups.
Conclusion
Based on the results from MTT assay, Alamar Blue assay and live cell imaging, although royal jelly has the potential to be used as an
alternative to FBS in cell culture, it does not exhibit similar ability like FBS to facilitate cell growth and proliferation under the present test
conditions.
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